Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG.

Cancer Res. 2006 Aug 15;66(16):8210-8.

2.

Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck.

Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM.

Cancer Res. 2004 Jan 1;64(1):55-63.

3.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR.

J Clin Oncol. 2006 Sep 1;24(25):4170-6.

PMID:
16943533
5.

Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells.

Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD.

Oncogene. 2002 Apr 18;21(17):2634-40.

6.

Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.

Gunduz E, Gunduz M, Beder L, Nagatsuka H, Fukushima K, Sutcu R, Delibas N, Yamanaka N, Shimizu K, Nagai N.

Arch Otolaryngol Head Neck Surg. 2009 Mar;135(3):254-60. doi: 10.1001/archoto.2008.560.

PMID:
19289703
7.

Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis.

Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA.

Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):760-70.

PMID:
12874079
8.

Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.

Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.

Laryngoscope. 2004 Dec;114(12):2063-72.

PMID:
15564824
9.

Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.

Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC.

J Pathol. 2008 Mar;214(4):489-97. doi: 10.1002/path.2306.

PMID:
18213732
10.

Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation.

Giri U, Ashorn CL, Ramdas L, Stivers DN, Coombes K, El-Naggar AK, Ang KK, Story MD.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):670-7. Epub 2005 Nov 10.

PMID:
16289374
11.

Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.

Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.

Clin Cancer Res. 2009 May 15;15(10):3557-67. doi: 10.1158/1078-0432.CCR-08-1656. Epub 2009 May 15.

12.

The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.

Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.

Mod Pathol. 2003 Sep;16(9):944-50.

13.

Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.

Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, Shockley WW, Weissler MC, Dressler LG, Shores CG, Yarbrough WG, Perou CM.

Cancer Cell. 2004 May;5(5):489-500.

14.

Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.

Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G.

Anticancer Res. 2000 Jan-Feb;20(1A):177-82.

PMID:
10769652
15.

Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.

Stokes A, Joutsa J, Ala-Aho R, Pitchers M, Pennington CJ, Martin C, Premachandra DJ, Okada Y, Peltonen J, Grénman R, James HA, Edwards DR, Kähäri VM.

Clin Cancer Res. 2010 Apr 1;16(7):2022-35. doi: 10.1158/1078-0432.CCR-09-2525. Epub 2010 Mar 21.

16.

Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.

Pramana J, Van den Brekel MW, van Velthuysen ML, Wessels LF, Nuyten DS, Hofland I, Atsma D, Pimentel N, Hoebers FJ, Rasch CR, Begg AC.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1544-52. Epub 2007 Oct 10.

PMID:
17931799
17.

cDNA microarray and bioinformatic analysis of nuclear factor-kappaB related genes in squamous cell carcinoma.

Chen Z, Lee TL, Yang XP, Dong G, Loercher A, Van Waes C.

Methods Mol Biol. 2007;383:81-99.

PMID:
18217680
18.

Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56.

19.

Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.

Squire JA, Bayani J, Luk C, Unwin L, Tokunaga J, MacMillan C, Irish J, Brown D, Gullane P, Kamel-Reid S.

Head Neck. 2002 Sep;24(9):874-87.

PMID:
12211052
20.

Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.

Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.

Oncogene. 2007 Mar 1;26(10):1385-97. Epub 2006 Sep 4.

PMID:
16953224

Supplemental Content

Support Center